Omnicell (OMCL) Financials

$25.66 -4.83 (-15.84%)

Closing price 05/6/2025 04:00 PM Eastern

Extended Trading

$25.87 +0.21 (+0.82%)

As of 07:50 AM Eastern

Annual Income Statements for Omnicell

This table shows Omnicell's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	31	31	9.76	31	38	61	32	78	5.65	-20	13
Consolidated Net Income / (Loss)	31	31	9.76	31	38	61	32	78	5.65	-20	13
Net Income / (Loss) Continuing Operations	31	31	9.76	31	38	61	32	78	5.65	-20	13
Total Pre-Tax Income	49	46	13	4.51	36	74	29	66	-2.45	-20	26
Total Operating Income	50	49	21	11	44	78	36	90	-2.32	-35	0.34
Total Gross Profit	234	248	317	319	372	437	413	555	589	497	471
Total Revenue	441	485	696	713	787	897	892	1,132	1,296	1,147	1,112
Operating Revenue	441	485	696	713	787	897	892	1,132	1,296	1,147	1,112
Total Cost of Revenue	207	237	379	394	415	460	479	577	707	650	641
Operating Cost of Revenue	207	237	379	394	415	460	479	577	707	650	641
Total Operating Expenses	184	199	296	307	328	359	378	465	591	532	471
Selling, General & Admin Expense	156	168	238	241	263	290	308	389	486	435	380
Research & Development Expense	28	35	58	66	65	69	70	76	105	97	90
Total Other Income / (Expense), net	-1.08	-2.39	-8.43	-6.63	-8.78	-4.42	-6.18	-24	-0.13	15	25
Other Income / (Expense), net	-1.08	-2.39	-8.43	-6.63	-8.78	-4.42	-6.18	-24	-0.13	15	25
Income Tax Expense	18	15	3.22	-26	-2.11	13	-2.85	-12	-8.10	0.26	13
Basic Earnings per Share	$0.86	$0.86	$0.27	$0.81	$0.96	$1.48	$0.76	$1.79	$0.13	($0.45)	$0.27
Weighted Average Basic Shares Outstanding	35.65M	35.86M	36.16M	37.48M	39.24M	41.46M	42.58M	43.48M	44.40M	45.21M	46.05M
Diluted Earnings per Share	$0.83	$0.84	$0.26	$0.79	$0.93	$1.43	$0.74	$1.62	$0.12	($0.45)	$0.27
Weighted Average Diluted Shares Outstanding	36.62M	36.72M	36.86M	38.71M	40.56M	42.94M	43.74M	47.94M	45.89M	45.21M	46.26M
Weighted Average Basic & Diluted Shares Outstanding	35.50M	35.80M	30.20M	37.70M	39.30M	42.47M	43.04M	44.42M	44.99M	45.92M	46.76M

This table shows Omnicell's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	17	-28	-15	3.45	5.55	-14	-16	3.74	8.63	16
Consolidated Net Income / (Loss)	17	-28	-15	3.45	5.55	-14	-16	3.74	8.63	16
Net Income / (Loss) Continuing Operations	17	-28	-15	3.45	5.55	-14	-16	3.74	8.63	16
Total Pre-Tax Income	17	-36	-21	12	7.38	-19	-18	8.20	12	24
Total Operating Income	18	-38	-23	7.75	3.71	-23	-22	3.22	6.56	12
Total Gross Profit	159	122	125	134	132	105	93	114	122	142
Total Revenue	348	298	291	299	299	259	246	277	282	307
Operating Revenue	348	298	291	299	299	259	246	277	282	307
Total Cost of Revenue	189	176	166	165	167	153	154	162	160	165
Operating Cost of Revenue	189	176	166	165	167	153	154	162	160	165
Total Operating Expenses	141	160	148	127	128	129	114	111	116	129
Selling, General & Admin Expense	115	132	125	104	104	102	92	90	94	103
Research & Development Expense	25	28	23	23	24	27	22	21	21	26
Total Other Income / (Expense), net	-1.15	2.84	1.78	4.46	3.67	4.85	4.02	4.97	5.06	11
Other Income / (Expense), net	-1.15	2.84	1.78	4.46	3.67	4.85	4.02	4.97	5.06	11
Income Tax Expense	0.54	-7.11	-6.18	8.76	1.83	-4.14	-2.16	4.46	3.00	7.76
Basic Earnings per Share	$0.38	($0.65)	($0.33)	$0.08	$0.12	($0.32)	($0.34)	$0.08	$0.19	$0.34
Weighted Average Basic Shares Outstanding	44.44M	44.40M	44.89M	45.13M	45.33M	45.21M	45.73M	45.95M	46.15M	46.05M
Diluted Earnings per Share	$0.37	($0.62)	($0.33)	$0.08	$0.12	($0.32)	($0.34)	$0.08	$0.19	$0.34
Weighted Average Diluted Shares Outstanding	45.82M	45.89M	44.89M	45.47M	45.60M	45.21M	45.73M	46.04M	46.43M	46.26M
Weighted Average Basic & Diluted Shares Outstanding	44.65M	44.99M	45.08M	45.21M	45.47M	45.92M	45.92M	45.99M	46.32M	46.76M

This table details how cash moves in and out of Omnicell's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	21	-44	-28	-22	35	60	363	-134	-2.79	148	-102
Net Cash From Operating Activities	65	38	50	25	104	145	186	232	78	181	188
Net Cash From Continuing Operating Activities	65	38	50	25	104	145	186	232	78	181	188
Net Income / (Loss) Continuing Operations	31	31	9.76	31	38	61	32	78	5.65	-20	13
Consolidated Net Income / (Loss)	31	31	9.76	31	38	61	32	78	5.65	-20	13
Depreciation Expense	20	26	58	52	51	54	61	73	87	87	82
Amortization Expense	0.00	0.00	1.59	1.59	2.29	13	17	34	16	13	11
Non-Cash Adjustments To Reconcile Net Income	7.47	12	14	18	24	32	37	47	84	76	36
Changes in Operating Assets and Liabilities, net	6.91	-30	-34	-77	-12	-14	39	0.26	-115	26	46
Net Cash From Investing Activities	-43	-46	-341	-35	-54	-62	-280	-412	-59	-55	-53
Net Cash From Continuing Investing Activities	-43	-46	-341	-35	-54	-62	-280	-412	-59	-55	-53
Purchase of Property, Plant & Equipment	-12	-7.54	-13	-15	-24	-16	-23	-29	-48	-41	-36
Acquisitions	-21	-26	-314	-4.61	0.00	0.00	-225	-354	2.07	0.00	0.00
Other Investing Activities, net	-10	-12	-14	-15	-31	-46	-32	-29	-13	-14	-16
Net Cash From Financing Activities	-0.21	-37	264	-9.88	-14	-23	456	47	-21	23	-236
Net Cash From Continuing Financing Activities	-0.21	-37	264	-9.88	-14	-23	456	47	-21	23	-235
Repayment of Debt	0.00	0.00	-35	-105	-77	-92	-201	0.00	0.00	-2.97	-391
Repurchase of Common Equity	-24	-50	-	-	0.00	0.00	-53	0.00	-52	0.00	0.00
Issuance of Debt	0.00	0.00	287	59	0.00	0.00	710	-	0.00	0.00	166
Issuance of Common Equity	22	17	18	44	70	79	106	67	40	23	39
Other Financing Activities, net	2.09	-3.63	-6.49	-8.29	-6.78	-9.67	-105	-20	-8.93	3.17	-49
Effect of Exchange Rate Changes	-0.28	-0.00	-0.06	-2.03	-1.23	0.15	0.44	-0.97	-0.94	-1.35	-1.72
Cash Interest Paid	0.06	0.08	5.34	6.55	7.49	3.58	0.52	1.92	1.44	1.44	1.62
Cash Income Taxes Paid	9.16	12	11	7.78	3.49	7.76	10	-1.73	19	20	11

This table details how cash moves in and out of Omnicell's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	15	69	3.17	62	45	38	49	28	15	-194
Net Cash From Operating Activities	21	82	13	73	57	38	50	59	23	56
Net Cash From Continuing Operating Activities	21	82	13	73	57	38	50	59	23	56
Net Income / (Loss) Continuing Operations	17	-28	-15	3.45	5.55	-14	-16	3.74	8.63	16
Consolidated Net Income / (Loss)	17	-28	-15	3.45	5.55	-14	-16	3.74	8.63	16
Depreciation Expense	22	22	22	22	22	22	21	21	20	20
Amortization Expense	3.95	3.57	3.29	3.02	3.06	3.26	2.90	2.94	2.35	3.12
Non-Cash Adjustments To Reconcile Net Income	21	19	25	16	17	17	11	16	12	-2.84
Changes in Operating Assets and Liabilities, net	-42	66	-23	28	9.93	10	31	15	-20	20
Net Cash From Investing Activities	-16	-17	-14	-15	-14	-12	-12	-14	-13	-14
Net Cash From Continuing Investing Activities	-16	-17	-14	-15	-14	-12	-12	-14	-13	-14
Purchase of Property, Plant & Equipment	-13	-14	-10	-12	-11	-9.07	-8.96	-9.55	-8.87	-9.09
Other Investing Activities, net	-8.59	-3.56	-3.50	-3.19	-3.56	-3.30	-3.38	-4.00	-4.47	-4.48
Net Cash From Financing Activities	9.06	3.56	3.86	3.60	2.83	13	12	-17	3.55	-234
Net Cash From Continuing Financing Activities	9.06	3.56	3.86	3.60	2.83	13	12	-17	3.55	-234
Issuance of Common Equity	18	0.64	12	3.09	7.83	0.18	8.04	0.10	5.00	25
Other Financing Activities, net	-9.36	2.92	-8.25	0.51	-5.01	16	3.88	-17	-1.45	-34
Effect of Exchange Rate Changes	0.70	0.48	0.18	-0.03	-0.61	-0.89	-0.56	-0.25	1.68	-2.60

This table presents Omnicell's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	560	579	935	1,016	1,081	1,241	1,825	2,142	2,211	2,227	2,121
Total Current Assets	283	264	315	352	397	483	829	781	882	928	815
Cash & Equivalents	126	82	54	32	67	127	486	349	330	468	369
Accounts Receivable	83	108	150	190	196	218	190	241	299	252	256
Inventories, net	32	47	69	96	101	108	96	120	148	110	89
Prepaid Expenses	24	20	29	20	21	14	16	22	27	26	26
Other Current Assets	7.22	7.77	13	13	12	15	41	48	77	72	75
Plant, Property, & Equipment, net	36	32	42	43	52	54	59	71	94	109	113
Total Noncurrent Assets	241	282	578	621	633	703	936	1,291	1,235	1,191	1,193
Noncurrent Note & Lease Receivables	11	14	21	15	17	20	22	18	33	43	53
Goodwill	123	148	328	338	336	337	499	739	734	736	735
Intangible Assets	83	90	190	168	144	125	168	278	243	211	188
Noncurrent Deferred & Refundable Income Taxes	1.14	2.36	4.04	9.45	15	14	15	16	22	33	57
Other Noncurrent Operating Assets	23	28	35	91	121	208	231	240	203	168	160
Total Liabilities & Shareholders' Equity	560	579	935	1,016	1,081	1,241	1,825	2,142	2,211	2,227	2,121
Total Liabilities	170	176	503	462	402	396	857	996	1,081	1,038	878
Total Current Liabilities	112	125	181	205	205	237	276	876	428	368	596
Short-Term Debt	-	0.00	8.41	15	-	-	0.00	488	-	0.00	174
Accounts Payable	19	23	27	48	38	46	40	72	63	45	52
Accrued Expenses	19	30	31	36	43	56	80	133	173	149	168
Current Deferred Revenue	54	54	88	79	82	91	100	112	119	122	141
Current Employee Benefit Liabilities	20	18	27	27	42	44	56	71	73	52	60
Total Noncurrent Liabilities	58	52	323	257	197	159	581	120	652	670	282
Long-Term Debt	-	0.00	246	195	135	50	467	0.00	567	570	166
Noncurrent Deferred Revenue	20	18	17	11	11	7.08	5.67	20	37	59	76
Noncurrent Deferred & Payable Income Tax Liabilities	30	22	52	41	41	39	40	52	2.10	1.62	1.11
Other Noncurrent Operating Liabilities	7.02	12	8.21	9.83	9.56	62	68	48	46	40	38
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	390	402	432	554	680	845	968	1,147	1,130	1,189	1,243
Total Preferred & Common Equity	390	402	432	554	680	845	968	1,147	1,130	1,189	1,243
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	390	402	432	554	680	845	968	1,147	1,130	1,189	1,243
Common Stock	457	490	526	586	678	781	920	1,025	1,047	1,122	1,168
Retained Earnings	69	100	100	160	197	259	291	369	391	370	383
Treasury Stock	-135	-185	-185	-185	-185	-185	-238	-238	-290	-	-290
Accumulated Other Comprehensive Income / (Loss)	-1.36	-2.73	-9.52	-6.11	-11	-9.45	-5.52	-8.41	-17	-13	-17

This table presents Omnicell's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	2,180	2,251	2,194	2,222	2,284	2,292	2,304
Total Current Assets	849	935	881	914	990	996	1,011
Cash & Equivalents	266	340	399	447	512	557	571
Accounts Receivable	354	322	274	273	249	241	252
Inventories, net	147	141	131	116	103	93	95
Prepaid Expenses	25	28	24	28	27	22	29
Other Current Assets	57	103	54	50	99	82	65
Plant, Property, & Equipment, net	88	98	103	107	109	111	112
Total Noncurrent Assets	1,242	1,217	1,209	1,201	1,185	1,185	1,181
Noncurrent Note & Lease Receivables	34	33	35	42	44	50	51
Goodwill	731	735	736	734	735	735	737
Intangible Assets	251	235	227	219	205	199	194
Noncurrent Deferred & Refundable Income Taxes	17	30	33	36	37	41	42
Other Noncurrent Operating Assets	209	186	179	170	163	159	157
Total Liabilities & Shareholders' Equity	2,180	2,251	2,194	2,222	2,284	2,292	2,304
Total Liabilities	1,044	1,108	1,030	1,034	1,095	1,089	1,072
Total Current Liabilities	377	454	370	369	416	407	962
Short-Term Debt	0.00	-	-	-	-	-	572
Accounts Payable	74	63	47	50	43	50	48
Accrued Expenses	146	199	146	150	167	158	144
Current Deferred Revenue	114	143	125	125	165	150	152
Current Employee Benefit Liabilities	43	48	52	44	41	49	45
Total Noncurrent Liabilities	668	654	660	665	679	682	111
Long-Term Debt	566	567	568	569	570	571	0.00
Noncurrent Deferred Revenue	35	42	49	55	65	68	70
Noncurrent Deferred & Payable Income Tax Liabilities	16	1.56	1.51	1.57	1.49	1.33	1.41
Other Noncurrent Operating Liabilities	51	43	42	39	42	41	40
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,135	1,143	1,164	1,187	1,189	1,203	1,231
Total Preferred & Common Equity	1,135	1,143	1,164	1,187	1,189	1,203	1,231
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,135	1,143	1,164	1,187	1,189	1,203	1,231
Common Stock	1,031	1,073	1,089	1,110	1,139	1,150	1,165
Retained Earnings	419	376	379	385	355	358	367
Treasury Stock	-290	-290	-290	-290	-290	-	-290
Accumulated Other Comprehensive Income / (Loss)	-24	-16	-14	-17	-15	-15	-10

This table displays calculated financial ratios and metrics derived from Omnicell's official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	15.85%	9.90%	43.62%	2.42%	10.47%	13.94%	-0.54%	26.88%	14.48%	-11.48%	-3.04%
EBITDA Growth	28.81%	4.52%	1.45%	-21.00%	54.93%	57.14%	-23.49%	61.21%	-41.68%	-20.85%	49.21%
EBIT Growth	38.47%	-4.66%	-71.94%	-65.23%	689.36%	107.58%	-60.30%	124.90%	-103.72%	-719.73%	227.28%
NOPAT Growth	29.11%	3.69%	-50.25%	368.40%	-37.62%	38.23%	-40.05%	170.89%	-101.54%	-1,400.99%	100.68%
Net Income Growth	27.27%	0.79%	-68.28%	212.81%	23.63%	62.58%	-47.51%	141.81%	-92.74%	-460.68%	161.51%
EPS Growth	23.88%	1.20%	-69.05%	203.85%	17.72%	53.76%	-48.25%	118.92%	-92.59%	-475.00%	160.00%
Operating Cash Flow Growth	17.91%	-40.94%	29.66%	-50.23%	318.64%	39.48%	28.18%	24.72%	-66.45%	132.83%	3.66%
Free Cash Flow Firm Growth	-54.07%	-306.17%	-1,149.32%	91.39%	222.94%	43.48%	-416.42%	-63.27%	64.49%	162.42%	48.12%
Invested Capital Growth	8.08%	21.18%	97.16%	15.97%	2.16%	2.70%	23.53%	35.52%	6.27%	-5.54%	-5.87%
Revenue Q/Q Growth	3.71%	1.84%	6.90%	3.05%	1.99%	4.25%	0.10%	5.78%	-1.02%	-3.27%	4.51%
EBITDA Q/Q Growth	5.22%	-0.78%	15.06%	-0.03%	3.63%	6.12%	0.09%	-2.15%	-30.98%	25.69%	50.96%
EBIT Q/Q Growth	5.38%	-4.50%	16.84%	48.47%	6.13%	7.81%	-21.62%	-9.68%	-106.15%	45.81%	254.88%
NOPAT Q/Q Growth	8.32%	-3.39%	18.41%	174.89%	-30.06%	9.85%	2.65%	-2.03%	-102.83%	30.07%	100.67%
Net Income Q/Q Growth	8.58%	-4.89%	20.43%	254.74%	-30.34%	13.51%	-15.08%	-2.99%	-88.24%	40.79%	170.85%
EPS Q/Q Growth	7.79%	-4.55%	18.18%	259.09%	-32.61%	11.72%	-15.91%	-5.81%	-88.24%	40.00%	169.23%
Operating Cash Flow Q/Q Growth	33.42%	4.64%	-14.82%	-44.22%	71.28%	-8.01%	28.86%	-6.76%	40.75%	-19.45%	10.54%
Free Cash Flow Firm Q/Q Growth	365.26%	7.71%	-15.17%	3.86%	188.44%	-37.51%	-516.81%	8.70%	68.96%	-43.27%	46.14%
Invested Capital Q/Q Growth	-3.82%	-4.08%	4.60%	11.36%	-1.59%	2.76%	26.28%	15.57%	-4.77%	-1.44%	-1.45%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	53.04%	51.17%	45.56%	44.71%	47.29%	48.71%	46.32%	49.00%	45.45%	43.31%	42.35%
EBITDA Margin	15.60%	14.83%	10.48%	8.08%	11.34%	15.64%	12.03%	15.28%	7.78%	6.96%	10.71%
Operating Margin	11.25%	10.04%	3.08%	1.56%	5.64%	8.73%	3.98%	7.91%	-0.18%	-3.04%	0.03%
EBIT Margin	11.00%	9.54%	1.86%	0.63%	4.52%	8.24%	3.29%	5.83%	-0.19%	-1.75%	2.30%
Profit (Net Income) Margin	6.92%	6.35%	1.40%	4.28%	4.79%	6.84%	3.61%	6.88%	0.44%	-1.78%	1.13%
Tax Burden Percent	62.92%	66.52%	75.19%	676.37%	105.93%	82.96%	109.69%	117.94%	-230.25%	101.31%	48.96%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	37.08%	33.48%	24.82%	-576.37%	-5.93%	17.04%	-9.69%	-17.94%	0.00%	0.00%	51.04%
Return on Invested Capital (ROIC)	12.27%	11.07%	3.38%	11.06%	6.36%	8.58%	4.54%	9.45%	-0.12%	-1.84%	0.01%
ROIC Less NNEP Spread (ROIC-NNEP)	12.86%	12.60%	-7.41%	-12.72%	-1.21%	90.18%	18.67%	-36.60%	3.75%	0.55%	33.80%
Return on Net Nonoperating Assets (RNNOA)	-4.01%	-3.31%	-1.04%	-4.87%	-0.24%	-0.53%	-0.99%	-2.08%	0.62%	0.08%	1.02%
Return on Equity (ROE)	8.26%	7.76%	2.34%	6.19%	6.12%	8.05%	3.55%	7.36%	0.50%	-1.76%	1.03%
Cash Return on Invested Capital (CROIC)	4.50%	-8.08%	-62.01%	-3.73%	4.22%	5.91%	-16.51%	-20.72%	-6.20%	3.86%	6.06%
Operating Return on Assets (OROA)	9.22%	8.12%	1.71%	0.46%	3.40%	6.37%	1.91%	3.33%	-0.11%	-0.91%	1.18%
Return on Assets (ROA)	5.80%	5.40%	1.29%	3.13%	3.60%	5.28%	2.10%	3.92%	0.26%	-0.92%	0.58%
Return on Common Equity (ROCE)	8.26%	7.76%	2.34%	6.19%	6.12%	8.05%	3.55%	7.36%	0.50%	-1.76%	1.03%
Return on Equity Simple (ROE_SIMPLE)	7.82%	7.64%	2.26%	5.51%	5.55%	7.26%	3.33%	6.79%	0.50%	-1.71%	1.01%
Net Operating Profit after Tax (NOPAT)	31	32	16	75	47	65	39	106	-1.63	-24	0.17
NOPAT Margin	7.08%	6.68%	2.31%	10.58%	5.97%	7.25%	4.37%	9.33%	-0.13%	-2.13%	0.01%
Net Nonoperating Expense Percent (NNEP)	-0.59%	-1.53%	10.79%	23.78%	7.56%	-81.61%	-14.13%	46.05%	-3.88%	-2.39%	-33.78%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-0.10%	-1.39%	0.01%
Cost of Revenue to Revenue	46.96%	48.83%	54.44%	55.29%	52.71%	51.29%	53.68%	51.00%	54.55%	56.69%	57.65%
SG&A Expenses to Revenue	35.49%	34.58%	34.18%	33.88%	33.42%	32.32%	34.48%	34.40%	37.53%	37.89%	34.19%
R&D to Revenue	6.31%	7.26%	8.31%	9.26%	8.24%	7.65%	7.86%	6.69%	8.10%	8.47%	8.13%
Operating Expenses to Revenue	41.80%	41.13%	42.49%	43.14%	41.65%	39.97%	42.34%	41.09%	45.63%	46.35%	42.32%
Earnings before Interest and Taxes (EBIT)	49	46	13	4.51	36	74	29	66	-2.45	-20	26
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	69	72	73	58	89	140	107	173	101	80	119
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.02	2.74	2.87	3.32	3.57	4.05	5.25	6.91	1.99	1.44	1.66
Price to Tangible Book Value (P/TBV)	6.38	6.68	0.00	37.95	12.13	8.93	16.93	60.91	14.72	7.07	6.44
Price to Revenue (P/Rev)	2.67	2.27	1.78	2.58	3.08	3.82	5.69	7.00	1.74	1.49	1.85
Price to Earnings (P/E)	38.64	35.80	126.89	60.28	64.32	55.87	157.72	101.85	398.59	0.00	164.55
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.59%	2.79%	0.79%	1.66%	1.55%	1.79%	0.63%	0.98%	0.25%	0.00%	0.61%
Enterprise Value to Invested Capital (EV/IC)	3.99	3.18	2.28	2.76	3.34	4.36	5.33	6.27	1.82	1.40	1.67
Enterprise Value to Revenue (EV/Rev)	2.39	2.10	2.07	2.83	3.17	3.73	5.67	7.13	1.92	1.58	1.83
Enterprise Value to EBITDA (EV/EBITDA)	15.32	14.17	19.71	35.02	27.95	23.88	47.14	46.64	24.66	22.70	17.07
Enterprise Value to EBIT (EV/EBIT)	21.72	22.03	110.79	447.12	70.05	45.31	172.37	122.23	0.00	0.00	79.46
Enterprise Value to NOPAT (EV/NOPAT)	33.76	31.50	89.33	26.76	53.05	51.53	129.82	76.43	0.00	0.00	12,324.22
Enterprise Value to Operating Cash Flow (EV/OCF)	16.16	26.47	28.81	81.24	24.00	23.10	27.22	34.81	31.98	10.01	10.83
Enterprise Value to Free Cash Flow (EV/FCFF)	91.97	0.00	0.00	0.00	79.90	74.77	0.00	0.00	0.00	35.34	26.77
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.59	0.38	0.20	0.06	0.48	0.43	0.50	0.48	0.27
Long-Term Debt to Equity	0.00	0.00	0.57	0.35	0.20	0.06	0.48	0.00	0.50	0.48	0.13
Financial Leverage	-0.31	-0.26	0.14	0.38	0.20	-0.01	-0.05	0.06	0.16	0.15	0.03
Leverage Ratio	1.42	1.44	1.82	1.98	1.70	1.52	1.69	1.88	1.91	1.91	1.79
Compound Leverage Factor	1.42	1.44	1.82	1.98	1.70	1.52	1.69	1.88	1.91	1.91	1.79
Debt to Total Capital	0.00%	0.00%	37.06%	27.49%	16.61%	5.59%	32.56%	29.86%	33.39%	32.39%	21.51%
Short-Term Debt to Total Capital	0.00%	0.00%	1.23%	1.99%	0.00%	0.00%	0.00%	29.86%	0.00%	0.00%	11.01%
Long-Term Debt to Total Capital	0.00%	0.00%	35.83%	25.50%	16.61%	5.59%	32.56%	0.00%	33.39%	32.39%	10.50%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	62.94%	72.51%	83.39%	94.42%	67.44%	70.14%	66.61%	67.61%	78.49%
Debt to EBITDA	0.00	0.00	3.48	3.65	1.52	0.36	4.35	2.82	5.62	7.13	2.86
Net Debt to EBITDA	0.00	0.00	2.74	3.08	0.76	-0.55	-0.17	0.80	2.34	1.27	-0.24
Long-Term Debt to EBITDA	0.00	0.00	3.37	3.38	1.52	0.36	4.35	0.00	5.62	7.13	1.40
Debt to NOPAT	0.00	0.00	15.79	2.79	2.88	0.77	11.99	4.62	-348.42	-23.34	2,064.93
Net Debt to NOPAT	0.00	0.00	12.41	2.36	1.45	-1.19	-0.48	1.32	-145.26	-4.17	-172.60
Long-Term Debt to NOPAT	0.00	0.00	15.27	2.59	2.88	0.77	11.99	0.00	-348.42	-23.34	1,008.44
Altman Z-Score	5.77	5.38	2.59	3.50	4.93	6.65	4.68	5.59	2.33	2.01	2.35
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.52	2.12	1.74	1.72	1.94	2.04	3.00	0.89	2.06	2.52	1.37
Quick Ratio	1.86	1.53	1.13	1.08	1.29	1.46	2.45	0.67	1.47	1.96	1.05
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	11	-24	-295	-25	31	45	-142	-231	-82	51	76
Operating Cash Flow to CapEx	546.58%	510.29%	371.14%	161.88%	438.73%	912.34%	813.72%	800.25%	163.63%	436.64%	514.83%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.84	0.85	0.92	0.73	0.75	0.77	0.58	0.57	0.60	0.52	0.51
Accounts Receivable Turnover	6.24	5.08	5.39	4.19	4.08	4.33	4.37	5.25	4.80	4.16	4.38
Inventory Turnover	6.57	6.06	6.54	4.76	4.21	4.41	4.69	5.34	5.29	5.05	6.45
Fixed Asset Turnover	12.34	14.15	18.73	16.85	16.73	16.97	15.75	17.39	15.70	11.33	10.05
Accounts Payable Turnover	11.53	11.25	15.24	10.46	9.61	10.90	11.05	10.33	10.48	12.00	13.25
Days Sales Outstanding (DSO)	58.51	71.83	67.73	87.15	89.54	84.35	83.55	69.49	76.10	87.74	83.42
Days Inventory Outstanding (DIO)	55.54	60.27	55.83	76.61	86.64	82.85	77.86	68.35	69.05	72.31	56.57
Days Payable Outstanding (DPO)	31.65	32.45	23.95	34.90	37.97	33.48	33.03	35.35	34.82	30.43	27.55
Cash Conversion Cycle (CCC)	82.41	99.65	99.61	128.87	138.22	133.72	128.38	102.49	110.32	129.62	112.44
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	264	320	631	732	748	768	949	1,286	1,366	1,291	1,215
Invested Capital Turnover	1.73	1.66	1.46	1.05	1.06	1.18	1.04	1.01	0.98	0.86	0.89
Increase / (Decrease) in Invested Capital	20	56	311	101	16	20	181	337	81	-76	-76
Enterprise Value (EV)	1,053	1,019	1,438	2,017	2,495	3,350	5,059	8,068	2,487	1,813	2,034
Market Capitalization	1,179	1,101	1,238	1,840	2,427	3,427	5,078	7,929	2,251	1,711	2,062
Book Value per Share	$10.96	$11.36	$11.82	$14.61	$17.15	$20.15	$22.87	$26.10	$25.31	$26.15	$26.84
Tangible Book Value per Share	$5.19	$4.65	($2.37)	$1.28	$5.05	$9.15	$7.09	$2.96	$3.43	$5.32	$6.92
Total Capital	390	402	686	764	815	895	1,435	1,635	1,697	1,759	1,584
Total Debt	0.00	0.00	254	210	135	50	467	488	567	570	341
Total Long-Term Debt	0.00	0.00	246	195	135	50	467	0.00	567	570	166
Net Debt	-126	-82	200	178	68	-77	-19	139	236	102	-28
Capital Expenditures (CapEx)	12	7.54	13	15	24	16	23	29	48	41	36
Debt-free, Cash-free Net Working Capital (DFCFNWC)	45	57	88	130	125	119	67	44	123	92	25
Debt-free Net Working Capital (DFNWC)	171	139	143	162	193	246	553	393	453	560	394
Net Working Capital (NWC)	171	139	134	147	193	246	553	-95	453	560	220
Net Nonoperating Expense (NNE)	0.68	1.59	6.34	45	9.30	3.67	6.78	28	-7.27	-4.04	-12
Net Nonoperating Obligations (NNO)	-126	-82	200	178	68	-77	-19	139	236	102	-28
Total Depreciation and Amortization (D&A)	20	26	60	53	54	66	78	107	103	100	94
Debt-free, Cash-free Net Working Capital to Revenue	10.24%	11.82%	12.71%	18.22%	15.92%	13.27%	7.52%	3.86%	9.49%	8.00%	2.24%
Debt-free Net Working Capital to Revenue	38.80%	28.79%	20.54%	22.77%	24.46%	27.45%	61.98%	34.69%	34.98%	48.80%	35.44%
Net Working Capital to Revenue	38.80%	28.79%	19.33%	20.63%	24.46%	27.45%	61.98%	-8.43%	34.98%	48.80%	19.76%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.86	$0.86	$0.02	$0.55	$0.96	$1.48	$0.76	$1.79	$0.13	($0.45)	$0.27
Adjusted Weighted Average Basic Shares Outstanding	35.65M	35.86M	36.16M	37.48M	39.24M	41.46M	42.58M	43.48M	44.40M	45.21M	46.05M
Adjusted Diluted Earnings per Share	$0.83	$0.84	$0.02	$0.53	$0.93	$1.43	$0.74	$1.62	$0.12	($0.45)	$0.27
Adjusted Weighted Average Diluted Shares Outstanding	36.62M	36.72M	36.86M	38.71M	40.56M	42.94M	43.74M	47.94M	45.89M	45.21M	46.26M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	36.17M	35.83M	36.95M	38.78M	40.80M	42.47M	43.04M	44.42M	44.99M	45.92M	46.76M
Normalized Net Operating Profit after Tax (NOPAT)	31	30	16	7.80	31	65	25	63	-1.63	-24	0.24
Normalized NOPAT Margin	7.08%	6.20%	2.31%	1.09%	3.95%	7.25%	2.79%	5.53%	-0.13%	-2.13%	0.02%
Pre Tax Income Margin	11.00%	9.54%	1.86%	0.63%	4.52%	8.24%	3.29%	5.83%	-0.19%	-1.75%	2.30%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	78.94%	162.62%	0.00%	0.00%	0.00%	0.00%	164.74%	0.00%	924.40%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Omnicell's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	17.43%	-4.30%	-8.84%	-9.78%	-14.19%	-13.04%	-15.30%	-7.42%	-5.44%	18.56%
EBITDA Growth	-13.84%	-127.81%	-86.58%	0.30%	-25.78%	165.61%	54.79%	-14.30%	6.79%	622.06%
EBIT Growth	-25.76%	-621.96%	-526.20%	13.32%	-57.37%	47.86%	15.82%	-32.86%	57.50%	227.45%
NOPAT Growth	-51.58%	-212.75%	-291.33%	-79.16%	-84.39%	39.09%	4.86%	-32.92%	74.48%	150.88%
Net Income Growth	-42.78%	-303.19%	-282.64%	-61.95%	-66.90%	49.40%	-4.51%	8.23%	55.41%	210.21%
EPS Growth	-39.34%	-321.43%	-294.12%	-60.00%	-67.57%	48.39%	-3.03%	0.00%	58.33%	206.25%
Operating Cash Flow Growth	-50.74%	37.77%	179.83%	863.30%	169.22%	-53.24%	291.17%	-19.48%	-60.09%	46.60%
Free Cash Flow Firm Growth	6.17%	65.71%	97.32%	117.00%	142.10%	155.25%	1,031.42%	40.81%	-36.26%	41.76%
Invested Capital Growth	28.96%	6.27%	-0.33%	-5.70%	-8.73%	-5.54%	-8.97%	-8.63%	-5.86%	-5.87%
Revenue Q/Q Growth	5.03%	-14.48%	-2.37%	2.87%	-0.10%	-13.33%	-4.90%	12.45%	2.03%	8.66%
EBITDA Q/Q Growth	15.84%	-122.87%	141.46%	813.39%	-14.28%	-79.79%	-2.20%	405.71%	6.82%	36.67%
EBIT Q/Q Growth	60.73%	-305.08%	40.36%	157.64%	-39.54%	-350.84%	3.70%	145.97%	41.84%	102.98%
NOPAT Q/Q Growth	70.19%	-250.12%	40.13%	113.62%	27.50%	-685.74%	6.50%	109.61%	231.65%	70.79%
Net Income Q/Q Growth	84.96%	-269.36%	47.20%	123.01%	60.91%	-358.87%	-9.05%	123.83%	131.06%	83.57%
EPS Q/Q Growth	85.00%	-267.57%	46.77%	124.24%	50.00%	-366.67%	-6.25%	123.53%	137.50%	78.95%
Operating Cash Flow Q/Q Growth	321.70%	287.97%	-84.46%	470.89%	-21.80%	-32.62%	30.04%	17.51%	-61.24%	147.49%
Free Cash Flow Firm Q/Q Growth	37.43%	64.70%	89.25%	816.46%	54.91%	-53.67%	81.15%	8.31%	-29.87%	3.03%
Invested Capital Q/Q Growth	1.56%	-4.77%	0.23%	-2.72%	-1.71%	-1.44%	-3.41%	-2.36%	1.27%	-1.45%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	45.71%	40.90%	43.02%	44.97%	44.18%	40.72%	37.63%	41.31%	43.29%	46.19%
EBITDA Margin	12.38%	-3.31%	1.41%	12.48%	10.71%	2.50%	2.57%	11.55%	12.09%	15.21%
Operating Margin	5.31%	-12.89%	-7.90%	2.59%	1.24%	-9.03%	-8.88%	1.16%	2.32%	4.04%
EBIT Margin	4.98%	-11.93%	-7.29%	4.08%	2.47%	-7.15%	-7.24%	2.96%	4.12%	7.69%
Profit (Net Income) Margin	4.82%	-9.54%	-5.16%	1.15%	1.86%	-5.55%	-6.37%	1.35%	3.06%	5.16%
Tax Burden Percent	96.86%	79.99%	70.81%	28.27%	75.22%	77.63%	87.91%	45.57%	74.22%	67.13%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	3.14%	0.00%	0.00%	71.73%	24.78%	0.00%	0.00%	54.43%	25.78%	32.87%
Return on Invested Capital (ROIC)	5.28%	-8.82%	-5.11%	0.66%	0.81%	-5.46%	-5.24%	0.45%	1.44%	2.41%
ROIC Less NNEP Spread (ROIC-NNEP)	4.54%	-9.65%	-4.70%	1.18%	2.12%	-4.28%	-5.51%	2.93%	7.53%	22.95%
Return on Net Nonoperating Assets (RNNOA)	0.61%	-1.59%	-1.12%	0.25%	0.38%	-0.62%	-0.67%	0.23%	0.38%	0.69%
Return on Equity (ROE)	5.89%	-10.40%	-6.23%	0.91%	1.19%	-6.08%	-5.91%	0.68%	1.83%	3.10%
Cash Return on Invested Capital (CROIC)	-20.79%	-6.20%	-1.22%	4.08%	6.59%	3.86%	7.58%	6.92%	4.09%	6.06%
Operating Return on Assets (OROA)	3.08%	-7.10%	-4.23%	2.33%	1.33%	-3.70%	-3.52%	1.43%	1.94%	3.93%
Return on Assets (ROA)	2.98%	-5.68%	-2.99%	0.66%	1.00%	-2.87%	-3.10%	0.65%	1.44%	2.64%
Return on Common Equity (ROCE)	5.89%	-10.40%	-6.23%	0.91%	1.19%	-6.08%	-5.91%	0.68%	1.83%	3.10%
Return on Equity Simple (ROE_SIMPLE)	4.23%	0.00%	-1.54%	-1.99%	-2.90%	0.00%	-1.77%	-1.73%	-1.44%	0.00%
Net Operating Profit after Tax (NOPAT)	18	-27	-16	2.19	2.79	-16	-15	1.47	4.87	8.32
NOPAT Margin	5.14%	-9.02%	-5.53%	0.73%	0.93%	-6.32%	-6.21%	0.53%	1.73%	2.71%
Net Nonoperating Expense Percent (NNEP)	0.74%	0.83%	-0.41%	-0.52%	-1.31%	-1.17%	0.27%	-2.48%	-6.09%	-20.55%
Return On Investment Capital (ROIC_SIMPLE)	-	-1.58%	-	-	-	-0.93%	-	-	-	0.53%
Cost of Revenue to Revenue	54.29%	59.10%	56.98%	55.03%	55.82%	59.28%	62.37%	58.69%	56.71%	53.81%
SG&A Expenses to Revenue	33.17%	44.24%	43.05%	34.64%	34.81%	39.39%	37.54%	32.52%	33.46%	33.67%
R&D to Revenue	7.23%	9.55%	7.87%	7.74%	8.13%	10.36%	8.96%	7.62%	7.51%	8.49%
Operating Expenses to Revenue	40.40%	53.79%	50.92%	42.38%	42.94%	49.75%	46.50%	40.15%	40.97%	42.16%
Earnings before Interest and Taxes (EBIT)	17	-36	-21	12	7.38	-19	-18	8.20	12	24
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	43	-9.85	4.09	37	32	6.47	6.32	32	34	47
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.39	1.99	2.31	2.85	1.71	1.44	1.13	1.03	1.63	1.66
Price to Tangible Book Value (P/TBV)	25.18	14.72	15.26	16.50	8.69	7.07	5.41	4.64	6.68	6.44
Price to Revenue (P/Rev)	2.94	1.74	2.08	2.69	1.72	1.49	1.22	1.15	1.88	1.85
Price to Earnings (P/E)	80.24	398.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	164.55
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.25%	0.25%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.61%
Enterprise Value to Invested Capital (EV/IC)	2.90	1.82	2.09	2.62	1.65	1.40	1.12	1.03	1.63	1.67
Enterprise Value to Revenue (EV/Rev)	3.17	1.92	2.26	2.82	1.82	1.58	1.27	1.16	1.89	1.83
Enterprise Value to EBITDA (EV/EBITDA)	28.42	24.66	38.46	46.76	33.98	22.70	17.06	16.39	25.43	17.07
Enterprise Value to EBIT (EV/EBIT)	104.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	79.46
Enterprise Value to NOPAT (EV/NOPAT)	72.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	12,324.22
Enterprise Value to Operating Cash Flow (EV/OCF)	75.17	31.98	26.90	18.46	9.60	10.01	6.41	6.16	11.82	10.83
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	62.40	23.87	35.34	14.12	14.26	38.60	26.77
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.50	0.50	0.50	0.49	0.48	0.48	0.48	0.47	0.46	0.27
Long-Term Debt to Equity	0.50	0.50	0.50	0.49	0.48	0.48	0.48	0.47	0.00	0.13
Financial Leverage	0.13	0.16	0.24	0.22	0.18	0.15	0.12	0.08	0.05	0.03
Leverage Ratio	1.88	1.91	1.97	1.92	1.89	1.91	1.95	1.90	1.87	1.79
Compound Leverage Factor	1.88	1.91	1.97	1.92	1.89	1.91	1.95	1.90	1.87	1.79
Debt to Total Capital	33.26%	33.39%	33.18%	32.81%	32.39%	32.39%	32.43%	32.20%	31.72%	21.51%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	31.72%	11.01%
Long-Term Debt to Total Capital	33.26%	33.39%	33.18%	32.81%	32.39%	32.39%	32.43%	32.20%	0.00%	10.50%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	66.74%	66.61%	66.82%	67.19%	67.61%	67.61%	67.57%	67.80%	68.28%	78.49%
Debt to EBITDA	3.87	5.62	7.61	7.61	8.95	7.13	6.95	7.44	7.25	2.86
Net Debt to EBITDA	2.05	2.34	3.05	2.26	1.92	1.27	0.71	0.19	0.02	-0.24
Long-Term Debt to EBITDA	3.87	5.62	7.61	7.61	8.95	7.13	6.95	7.44	0.00	1.40
Debt to NOPAT	9.86	-348.42	-26.69	-23.12	-16.30	-23.34	-24.14	-21.32	-23.07	2,064.93
Net Debt to NOPAT	5.22	-145.26	-10.67	-6.86	-3.50	-4.17	-2.46	-0.54	-0.06	-172.60
Long-Term Debt to NOPAT	9.86	-348.42	-26.69	-23.12	-16.30	-23.34	-24.14	-21.32	0.00	1,008.44
Altman Z-Score	3.37	2.28	2.45	3.04	2.26	2.01	1.71	1.70	1.85	2.35
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.25	2.06	2.06	2.38	2.47	2.52	2.38	2.45	1.05	1.37
Quick Ratio	1.65	1.47	1.46	1.82	1.95	1.96	1.83	1.96	0.86	1.05
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-304	-107	-12	83	128	59	108	116	82	84
Operating Cash Flow to CapEx	165.92%	600.75%	125.92%	626.80%	536.18%	423.53%	557.70%	614.60%	256.59%	619.73%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.62	0.60	0.58	0.57	0.54	0.52	0.49	0.48	0.47	0.51
Accounts Receivable Turnover	4.45	4.80	4.14	4.23	3.78	4.16	3.86	4.20	4.06	4.38
Inventory Turnover	5.51	5.29	5.06	4.95	5.11	5.05	5.22	5.68	5.96	6.45
Fixed Asset Turnover	17.08	15.70	14.45	13.35	12.15	11.33	10.63	10.09	9.74	10.05
Accounts Payable Turnover	9.35	10.48	10.42	12.03	10.90	12.00	11.98	13.12	12.88	13.25
Days Sales Outstanding (DSO)	81.94	76.10	88.18	86.34	96.44	87.74	94.44	86.99	89.92	83.42
Days Inventory Outstanding (DIO)	66.21	69.05	72.14	73.80	71.41	72.31	69.95	64.22	61.22	56.57
Days Payable Outstanding (DPO)	39.03	34.82	35.02	30.35	33.49	30.43	30.47	27.81	28.33	27.55
Cash Conversion Cycle (CCC)	109.12	110.32	125.30	129.78	134.36	129.62	133.92	123.40	122.81	112.44
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,435	1,366	1,369	1,332	1,309	1,291	1,247	1,217	1,233	1,215
Invested Capital Turnover	1.03	0.98	0.92	0.90	0.86	0.86	0.84	0.85	0.84	0.89
Increase / (Decrease) in Invested Capital	322	81	-4.53	-81	-125	-76	-123	-115	-77	-76
Enterprise Value (EV)	4,154	2,487	2,866	3,490	2,158	1,813	1,400	1,258	2,007	2,034
Market Capitalization	3,854	2,251	2,639	3,321	2,036	1,711	1,342	1,243	2,005	2,062
Book Value per Share	$25.64	$25.31	$25.40	$25.81	$26.26	$26.15	$25.89	$26.19	$26.77	$26.84
Tangible Book Value per Share	$3.46	$3.43	$3.84	$4.47	$5.18	$5.32	$5.40	$5.84	$6.53	$6.92
Total Capital	1,701	1,697	1,710	1,732	1,756	1,759	1,759	1,774	1,803	1,584
Total Debt	566	567	567	568	569	570	570	571	572	341
Total Long-Term Debt	566	567	567	568	569	570	570	571	0.00	166
Net Debt	299	236	227	169	122	102	58	14	1.37	-28
Capital Expenditures (CapEx)	13	14	10	12	11	9.07	8.96	9.55	8.87	9.09
Debt-free, Cash-free Net Working Capital (DFCFNWC)	206	123	141	112	98	92	61	32	51	25
Debt-free Net Working Capital (DFNWC)	472	453	481	511	544	560	574	589	622	394
Net Working Capital (NWC)	472	453	481	511	544	560	574	589	50	220
Net Nonoperating Expense (NNE)	1.11	1.56	-1.07	-1.26	-2.76	-1.98	0.38	-2.27	-3.76	-7.52
Net Nonoperating Obligations (NNO)	299	236	227	169	122	102	58	14	1.37	-28
Total Depreciation and Amortization (D&A)	26	26	25	25	25	25	24	24	23	23
Debt-free, Cash-free Net Working Capital to Revenue	15.74%	9.49%	11.09%	9.05%	8.23%	8.00%	5.55%	2.94%	4.80%	2.24%
Debt-free Net Working Capital to Revenue	36.08%	34.98%	37.94%	41.38%	45.90%	48.80%	52.02%	54.47%	58.42%	35.44%
Net Working Capital to Revenue	36.08%	34.98%	37.94%	41.38%	45.90%	48.80%	52.02%	54.47%	4.67%	19.76%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.38	($0.65)	($0.33)	$0.08	$0.12	($0.32)	($0.34)	$0.08	$0.19	$0.34
Adjusted Weighted Average Basic Shares Outstanding	44.44M	44.40M	44.89M	45.13M	45.33M	45.21M	45.73M	45.95M	46.15M	46.05M
Adjusted Diluted Earnings per Share	$0.37	($0.62)	($0.33)	$0.08	$0.12	($0.32)	($0.34)	$0.08	$0.19	$0.34
Adjusted Weighted Average Diluted Shares Outstanding	45.82M	45.89M	44.89M	45.47M	45.60M	45.21M	45.73M	46.04M	46.43M	46.26M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	44.65M	44.99M	45.08M	45.21M	45.47M	45.92M	45.92M	45.99M	46.32M	46.76M
Normalized Net Operating Profit after Tax (NOPAT)	18	-27	-16	5.42	2.79	-16	-15	2.26	4.87	8.32
Normalized NOPAT Margin	5.14%	-9.02%	-5.53%	1.81%	0.93%	-6.32%	-6.21%	0.82%	1.73%	2.71%
Pre Tax Income Margin	4.98%	-11.93%	-7.29%	4.08%	2.47%	-7.15%	-7.24%	2.96%	4.12%	7.69%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	108.69%	924.40%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Omnicell's Financials

When does Omnicell's fiscal year end?

According to the most recent income statement we have on file, Omnicell's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Omnicell's net income changed over the last 10 years?

Omnicell's net income appears to be on a downward trend, with a most recent value of $12.53 million in 2024, falling from $30.52 million in 2014. The previous period was -$20.37 million in 2023. See Omnicell's forecast for analyst expectations on what’s next for the company.

What is Omnicell's operating income?

Omnicell's total operating income in 2024 was $337 thousand, based on the following breakdown:

Total Gross Profit: $471.00 million
Total Operating Expenses: $470.67 million

How has Omnicell revenue changed over the last 10 years?

Over the last 10 years, Omnicell's total revenue changed from $440.90 million in 2014 to $1.11 billion in 2024, a change of 152.3%.

How much debt does Omnicell have?

Omnicell's total liabilities were at $877.65 million at the end of 2024, a 15.4% decrease from 2023, and a 415.9% increase since 2014.

How much cash does Omnicell have?

In the past 10 years, Omnicell's cash and equivalents has ranged from $32.42 million in 2017 to $485.93 million in 2020, and is currently $369.20 million as of their latest financial filing in 2024.

How has Omnicell's book value per share changed over the last 10 years?

Over the last 10 years, Omnicell's book value per share changed from 10.96 in 2014 to 26.84 in 2024, a change of 145.0%.

Related Companies

This page (NASDAQ:OMCL) was last updated on 5/7/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Omnicell (OMCL) Financials

Frequently Asked Questions About Omnicell's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Omnicell (OMCL) Financials

Annual Income Statements for Omnicell

Quarterly Income Statements for Omnicell

Annual Cash Flow Statements for Omnicell

Quarterly Cash Flow Statements for Omnicell

Annual Balance Sheets for Omnicell

Quarterly Balance Sheets for Omnicell

Annual Metrics and Ratios for Omnicell

Quarterly Metrics and Ratios for Omnicell

Frequently Asked Questions About Omnicell's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools